Assessing the efficacy and safety of novel drug candidates for Alzheimer's disease utilizes a rigorous evaluation process. Preclinical studies typically involve in vitro and in vivo experiments to assess its potential effectiveness in targeting disease-related pathways. Once promising candidates emerge, they undergo clinical trials that are conduc